|
1
|
Heart disease and stroke statistics--2015 update: a report from the American Heart Association.
|
Circulation
|
2014
|
22.74
|
|
2
|
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.
|
Circulation
|
2015
|
10.14
|
|
3
|
Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis.
|
Diabetes Care
|
2010
|
8.52
|
|
4
|
Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk.
|
Circulation
|
2010
|
6.86
|
|
5
|
Pathophysiology of human visceral obesity: an update.
|
Physiol Rev
|
2013
|
4.41
|
|
6
|
Short sleep duration is associated with reduced leptin levels and increased adiposity: Results from the Quebec family study.
|
Obesity (Silver Spring)
|
2007
|
3.23
|
|
7
|
Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial.
|
JAMA
|
2008
|
3.09
|
|
8
|
International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries.
|
Circulation
|
2007
|
3.01
|
|
9
|
Assessing adiposity: a scientific statement from the American Heart Association.
|
Circulation
|
2011
|
3.00
|
|
10
|
Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.
|
Circulation
|
2016
|
2.87
|
|
11
|
Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study.
|
Arterioscler Thromb Vasc Biol
|
2004
|
2.50
|
|
12
|
Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women.
|
J Am Coll Cardiol
|
2009
|
2.50
|
|
13
|
The association between sleep duration and weight gain in adults: a 6-year prospective study from the Quebec Family Study.
|
Sleep
|
2008
|
2.30
|
|
14
|
High-density lipoprotein particle size and concentration and coronary risk.
|
Ann Intern Med
|
2009
|
2.02
|
|
15
|
Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program.
|
Diabetes Care
|
2008
|
2.00
|
|
16
|
Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease.
|
Hypertension
|
2009
|
2.00
|
|
17
|
Insulin resistance syndrome, body mass index and the risk of ischemic heart disease.
|
CMAJ
|
2005
|
1.86
|
|
18
|
Impact of waist circumference on the relationship between blood pressure and insulin: the Quebec Health Survey.
|
Hypertension
|
2005
|
1.83
|
|
19
|
Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology?
|
Can J Cardiol
|
2007
|
1.64
|
|
20
|
Aging per se does not influence glucose homeostasis: in vivo and in vitro evidence.
|
Diabetes Care
|
2003
|
1.62
|
|
21
|
Visceral obesity and the heart.
|
Int J Biochem Cell Biol
|
2007
|
1.58
|
|
22
|
Middle-aged men with increased waist circumference and elevated C-reactive protein level are at higher risk for postoperative atrial fibrillation following coronary artery bypass grafting surgery.
|
Eur Heart J
|
2009
|
1.57
|
|
23
|
Metabolic syndrome is associated with faster degeneration of bioprosthetic valves.
|
Circulation
|
2006
|
1.55
|
|
24
|
The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension.
|
Eur J Clin Pharmacol
|
2007
|
1.54
|
|
25
|
Sex differences in inflammatory markers: what is the contribution of visceral adiposity?
|
Am J Clin Nutr
|
2009
|
1.51
|
|
26
|
Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk.
|
Am J Cardiol
|
2003
|
1.50
|
|
27
|
Sleep duration as a risk factor for the development of type 2 diabetes or impaired glucose tolerance: analyses of the Quebec Family Study.
|
Sleep Med
|
2009
|
1.49
|
|
28
|
Diabetes: Looking back at Look AHEAD--giving lifestyle a chance.
|
Nat Rev Cardiol
|
2013
|
1.49
|
|
29
|
Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics.
|
J Clin Psychiatry
|
2004
|
1.49
|
|
30
|
Evidence for impaired lipolysis in abdominally obese men: postprandial study of apolipoprotein B-48- and B-100-containing lipoproteins.
|
Am J Clin Nutr
|
2002
|
1.49
|
|
31
|
Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions: the moderate vein graft lesion stenting with the taxus stent and intravascular ultrasound (VELETI) pilot trial.
|
Circulation
|
2009
|
1.47
|
|
32
|
Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship With Cardiometabolic Risk/Intra-Abdominal Adiposity.
|
Am J Clin Nutr
|
2012
|
1.45
|
|
33
|
The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk prospective population study.
|
CMAJ
|
2010
|
1.45
|
|
34
|
Waist circumference, visceral obesity, and cardiovascular risk.
|
J Cardiopulm Rehabil
|
2003
|
1.43
|
|
35
|
Eating behaviors and indexes of body composition in men and women from the Québec family study.
|
Obes Res
|
2003
|
1.41
|
|
36
|
Elevated proportion of small, dense low-density lipoprotein particles and lower adiponectin blood levels predict early structural valve degeneration of bioprostheses.
|
Cardiology
|
2012
|
1.40
|
|
37
|
Calcium intake, body composition, and lipoprotein-lipid concentrations in adults.
|
Am J Clin Nutr
|
2003
|
1.40
|
|
38
|
Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men.
|
J Clin Endocrinol Metab
|
2008
|
1.39
|
|
39
|
Exercise-induced hypertension in men with metabolic syndrome: anthropometric, metabolic, and hemodynamic features.
|
Metab Syndr Relat Disord
|
2012
|
1.39
|
|
40
|
Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men.
|
J Clin Endocrinol Metab
|
2004
|
1.36
|
|
41
|
Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and women.
|
Eur Heart J
|
2009
|
1.31
|
|
42
|
What is a normal glucose value? Differences in indexes of plasma glucose homeostasis in subjects with normal fasting glucose.
|
Diabetes Care
|
2004
|
1.29
|
|
43
|
Visceral adipose tissue accumulation, cardiorespiratory fitness, and features of the metabolic syndrome.
|
Arch Intern Med
|
2007
|
1.26
|
|
44
|
Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery.
|
Circulation
|
2007
|
1.26
|
|
45
|
Postprandial variations of plasma inflammatory markers in abdominally obese men.
|
Obesity (Silver Spring)
|
2006
|
1.25
|
|
46
|
Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group.
|
Can J Cardiol
|
2011
|
1.24
|
|
47
|
Relation of the "hypertriglyceridemic waist" phenotype to earlier manifestations of coronary artery disease in patients with glucose intolerance and type 2 diabetes mellitus.
|
Am J Cardiol
|
2006
|
1.23
|
|
48
|
Disease prevention--should we target obesity or sedentary lifestyle?
|
Nat Rev Cardiol
|
2010
|
1.22
|
|
49
|
HDL particle size and the risk of coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study.
|
Atherosclerosis
|
2009
|
1.21
|
|
50
|
Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study.
|
J Clin Endocrinol Metab
|
2012
|
1.21
|
|
51
|
Risk factors for adult overweight and obesity in the Quebec Family Study: have we been barking up the wrong tree?
|
Obesity (Silver Spring)
|
2009
|
1.18
|
|
52
|
5' flanking variants of resistin are associated with obesity.
|
Diabetes
|
2002
|
1.16
|
|
53
|
Modifications in food-group consumption are related to long-term body-weight changes.
|
Am J Clin Nutr
|
2004
|
1.16
|
|
54
|
Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease.
|
Am J Cardiol
|
2002
|
1.15
|
|
55
|
Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program.
|
Obesity (Silver Spring)
|
2012
|
1.14
|
|
56
|
The association between short sleep duration and weight gain is dependent on disinhibited eating behavior in adults.
|
Sleep
|
2011
|
1.14
|
|
57
|
Effect of exercise training on cardiometabolic risk markers among sedentary, but metabolically healthy overweight or obese post-menopausal women with elevated blood pressure.
|
Atherosclerosis
|
2009
|
1.13
|
|
58
|
Metabolic syndrome: the danger signal in atherosclerosis.
|
Vasc Health Risk Manag
|
2006
|
1.13
|
|
59
|
CB1 antagonists for obesity--what lessons have we learned from rimonabant?
|
Nat Rev Endocrinol
|
2009
|
1.12
|
|
60
|
Age-related differences in inflammatory markers in men: contribution of visceral adiposity.
|
Metabolism
|
2009
|
1.11
|
|
61
|
Prevalence of 'hypertriglyceridemic waist' in men who participated in the Quebec Health Survey: association with atherogenic and diabetogenic metabolic risk factors.
|
Can J Cardiol
|
2002
|
1.11
|
|
62
|
Hypertriglyceridemic waist: a simple clinical phenotype associated with coronary artery disease in women.
|
Metabolism
|
2011
|
1.10
|
|
63
|
Inflammatory markers and long-term risk of ischemic heart disease in men A 13-year follow-up of the Quebec Cardiovascular Study.
|
Atherosclerosis
|
2005
|
1.09
|
|
64
|
Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis.
|
Arterioscler Thromb Vasc Biol
|
2007
|
1.06
|
|
65
|
Sex differences in postprandial plasma tumor necrosis factor-alpha, interleukin-6, and C-reactive protein concentrations.
|
Metabolism
|
2009
|
1.04
|
|
66
|
Cholesterol levels in small LDL particles predict the risk of coronary heart disease in the EPIC-Norfolk prospective population study.
|
Eur Heart J
|
2007
|
1.04
|
|
67
|
Contribution of age and declining androgen levels to features of the metabolic syndrome in men.
|
Metabolism
|
2005
|
1.04
|
|
68
|
Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis.
|
J Am Coll Cardiol
|
2006
|
1.03
|
|
69
|
Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery.
|
J Am Coll Cardiol
|
2007
|
1.03
|
|
70
|
Moderate alcohol consumption is more cardioprotective in men with the metabolic syndrome.
|
J Nutr
|
2006
|
1.02
|
|
71
|
Greater than predicted decrease in energy expenditure during exercise after body weight loss in obese men.
|
Clin Sci (Lond)
|
2003
|
1.02
|
|
72
|
Metabolic syndrome is associated with more pronounced impairment of left ventricle geometry and function in patients with calcific aortic stenosis: a substudy of the ASTRONOMER (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin).
|
J Am Coll Cardiol
|
2010
|
1.01
|
|
73
|
The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile.
|
Metabolism
|
2009
|
1.01
|
|
74
|
Sleep apnoea attenuates the effects of a lifestyle intervention programme in men with visceral obesity.
|
Thorax
|
2012
|
1.00
|
|
75
|
Mapping body fat distribution: a key step towards the identification of the vulnerable patient?
|
Ann Med
|
2011
|
1.00
|
|
76
|
Contributions of cardiorespiratory fitness and visceral adiposity to six-year changes in cardiometabolic risk markers in apparently healthy men and women.
|
J Clin Endocrinol Metab
|
2011
|
1.00
|
|
77
|
Glucose homeostasis predicts weight gain: prospective and clinical evidence.
|
Diabetes Metab Res Rev
|
2008
|
0.99
|
|
78
|
Relationship between sex hormone-binding globulin levels and features of the metabolic syndrome.
|
Metabolism
|
2003
|
0.98
|
|
79
|
Familial resemblance in eating behaviors in men and women from the Quebec Family Study.
|
Obes Res
|
2005
|
0.97
|
|
80
|
Association of lipin 1 gene polymorphisms with measures of energy and glucose metabolism.
|
Obesity (Silver Spring)
|
2007
|
0.96
|
|
81
|
Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary).
|
Can J Cardiol
|
2011
|
0.96
|
|
82
|
Familial aggregation of blood lipid response to exercise training in the health, risk factors, exercise training, and genetics (HERITAGE) Family Study.
|
Circulation
|
2002
|
0.95
|
|
83
|
Eating behaviours, dietary profile and body composition according to dieting history in men and women of the Québec Family Study.
|
Br J Nutr
|
2004
|
0.95
|
|
84
|
CRP and risk of coronary heart disease: can exercise training cool down the flames?
|
Arterioscler Thromb Vasc Biol
|
2004
|
0.95
|
|
85
|
Excess visceral adipose tissue/ectopic fat the missing link in the obesity paradox?
|
J Am Coll Cardiol
|
2011
|
0.94
|
|
86
|
Influence of obesity indices, metabolic parameters and age on cardiac autonomic function in abdominally obese men.
|
Metabolism
|
2012
|
0.94
|
|
87
|
Short sleep duration is associated with greater alcohol consumption in adults.
|
Appetite
|
2012
|
0.94
|
|
88
|
The interleukin 6-174G/C polymorphism is associated with indices of obesity in men.
|
J Hum Genet
|
2003
|
0.94
|
|
89
|
Increased biglycan in aortic valve stenosis leads to the overexpression of phospholipid transfer protein via Toll-like receptor 2.
|
Am J Pathol
|
2010
|
0.94
|
|
90
|
Does abdominal obesity have a similar impact on cardiovascular disease and diabetes? A study of 91,246 ambulant patients in 27 European countries.
|
Eur Heart J
|
2009
|
0.94
|
|
91
|
Contribution of visceral adiposity to the exaggerated postprandial lipemia of men with impaired glucose tolerance.
|
Diabetes Care
|
2003
|
0.93
|
|
92
|
Risk factors for adult overweight and obesity: the importance of looking beyond the 'big two'.
|
Obes Facts
|
2010
|
0.93
|
|
93
|
Short sleep duration as a risk factor for the development of the metabolic syndrome in adults.
|
Prev Med
|
2013
|
0.93
|
|
94
|
Quantitative trait locus on 15q for a metabolic syndrome variable derived from factor analysis.
|
Obesity (Silver Spring)
|
2007
|
0.92
|
|
95
|
Improvement in insulin sensitivity following a 1-year lifestyle intervention program in viscerally obese men: contribution of abdominal adiposity.
|
Metabolism
|
2011
|
0.92
|
|
96
|
Associations between the fatty acid content of triglyceride, visceral adipose tissue accumulation, and components of the insulin resistance syndrome.
|
Metabolism
|
2004
|
0.92
|
|
97
|
Physical activity, the Framingham risk score and risk of coronary heart disease in men and women of the EPIC-Norfolk study.
|
Atherosclerosis
|
2009
|
0.92
|
|
98
|
Plasma organochlorine concentrations in endurance athletes and obese individuals.
|
Med Sci Sports Exerc
|
2002
|
0.92
|
|
99
|
Type 2 diabetes without the atherogenic metabolic triad does not predict angiographically assessed coronary artery disease in women.
|
Diabetes Care
|
2007
|
0.92
|
|
100
|
Usefulness of hypertriglyceridemic waist phenotype in type 2 diabetes mellitus to predict the presence of coronary artery disease as assessed by computed tomographic coronary angiography.
|
Am J Cardiol
|
2010
|
0.91
|
|
101
|
Efficacy and safety of the weight-loss drug rimonabant.
|
Lancet
|
2008
|
0.91
|
|
102
|
Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.
|
Am J Cardiol
|
2006
|
0.91
|
|
103
|
The utility of the international child and adolescent overweight guidelines for predicting coronary heart disease risk factors.
|
J Clin Epidemiol
|
2003
|
0.90
|
|
104
|
What is "metabolically healthy obesity"?: from epidemiology to pathophysiological insights.
|
J Clin Endocrinol Metab
|
2012
|
0.90
|
|
105
|
Hepatic lipase gene variant -514C>T is associated with lipoprotein and insulin sensitivity response to regular exercise: the HERITAGE Family Study.
|
Diabetes
|
2005
|
0.90
|
|
106
|
Normalization of visceral adiposity is required to normalize plasma apolipoprotein B levels in response to a healthy eating/physical activity lifestyle modification program in viscerally obese men.
|
Atherosclerosis
|
2012
|
0.90
|
|
107
|
Body composition, cardiorespiratory fitness, and low-grade inflammation in middle-aged men and women.
|
Am J Cardiol
|
2009
|
0.90
|
|
108
|
Perivascular adipose tissue in the pathogenesis of cardiovascular disease.
|
Atherosclerosis
|
2013
|
0.89
|
|
109
|
The peroxisome proliferator-activated receptor alpha L162V mutation is associated with reduced adiposity.
|
Obes Res
|
2003
|
0.89
|
|
110
|
The obesity epidemic.
|
Clin Chem
|
2012
|
0.88
|
|
111
|
Compendium of genome-wide scans of lipid-related phenotypes: adding a new genome-wide search of apolipoprotein levels.
|
J Lipid Res
|
2004
|
0.88
|
|
112
|
Visceral obesity attenuates the effect of the hepatic lipase -514C>T polymorphism on plasma HDL-cholesterol levels in French-Canadian men.
|
Mol Genet Metab
|
2003
|
0.88
|
|
113
|
Abdominal obesity, insulin resistance, and the metabolic syndrome: contribution of physical activity/exercise.
|
Obesity (Silver Spring)
|
2009
|
0.88
|
|
114
|
Metabolic dyslipidemia and risk of future coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study.
|
Int J Cardiol
|
2009
|
0.87
|
|
115
|
Increased plasma interleukin-1 receptor antagonist levels in men with visceral obesity.
|
Ann Med
|
2009
|
0.87
|
|
116
|
Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities: analysis of pooled RIO study results.
|
J Hypertens
|
2008
|
0.87
|
|
117
|
Angiotensin receptor blockers are associated with a lower remodelling score of stenotic aortic valves.
|
Eur J Clin Invest
|
2011
|
0.87
|
|
118
|
The quest for the optimal assessment of global cardiovascular risk: are traditional risk factors and metabolic syndrome partners in crime?
|
Cardiology
|
2008
|
0.87
|
|
119
|
Low cardiorespiratory fitness levels and elevated blood pressure: what is the contribution of visceral adiposity?
|
Hypertension
|
2009
|
0.87
|
|
120
|
Age-related differences in the pathogenesis of calcific aortic stenosis: the potential role of resistin.
|
Int J Cardiol
|
2009
|
0.86
|
|
121
|
Acute exercise increases adiponectin levels in abdominally obese men.
|
J Nutr Metab
|
2012
|
0.86
|
|
122
|
Effects of prednisone withdrawal on the new metabolic triad in cyclosporine-treated kidney transplant patients.
|
Kidney Int
|
2002
|
0.86
|
|
123
|
Identification and management of patients at elevated cardiometabolic risk in canadian primary care: how well are we doing?
|
Can J Cardiol
|
2013
|
0.86
|
|
124
|
Adiponectin and risk of coronary heart disease in apparently healthy men and women (from the EPIC-Norfolk Prospective Population Study).
|
Am J Cardiol
|
2011
|
0.86
|
|
125
|
Gemfibrozil reduces plasma C-reactive protein levels in abdominally obese men with the atherogenic dyslipidemia of the metabolic syndrome.
|
Arterioscler Thromb Vasc Biol
|
2003
|
0.86
|
|
126
|
Comparison between gradient gel electrophoresis and nuclear magnetic resonance spectroscopy in estimating coronary heart disease risk associated with LDL and HDL particle size.
|
Clin Chem
|
2010
|
0.86
|
|
127
|
Comparison of two techniques for measurement of visceral adipose tissue cross-sectional areas by computed tomography.
|
Am J Hum Biol
|
1999
|
0.86
|
|
128
|
Long-term adiposity changes are related to a glucocorticoid receptor polymorphism in young females.
|
J Clin Endocrinol Metab
|
2003
|
0.85
|
|
129
|
Ethnic differences in body composition and other markers of cardiovascular disease risk: study in matched Haitian and White subjects from Quebec.
|
Obesity (Silver Spring)
|
2006
|
0.85
|
|
130
|
Lipid assessment, metabolic syndrome and coronary heart disease risk.
|
Eur J Clin Invest
|
2010
|
0.85
|
|
131
|
Seven to eight hours of sleep a night is associated with a lower prevalence of the metabolic syndrome and reduced overall cardiometabolic risk in adults.
|
PLoS One
|
2013
|
0.85
|
|
132
|
HDL cholesterol is not HDL--don't judge the book by its cover.
|
Nat Rev Cardiol
|
2012
|
0.85
|
|
133
|
The National Physical Activity Plan: a call to action from the American Heart Association: a science advisory from the American Heart Association.
|
Circulation
|
2015
|
0.84
|
|
134
|
ATP acts as a survival signal and prevents the mineralization of aortic valve.
|
J Mol Cell Cardiol
|
2012
|
0.84
|
|
135
|
At-risk serum cholesterol profile at both ends of the nutrition spectrum in West African adults? The Benin study.
|
Nutrients
|
2013
|
0.84
|
|
136
|
Pleiotropic QTL on chromosome 12q23-q24 influences triglyceride and high-density lipoprotein cholesterol levels: the HERITAGE family study.
|
Hum Biol
|
2006
|
0.84
|
|
137
|
Sedentary behaviour, visceral fat accumulation and cardiometabolic risk in adults: a 6-year longitudinal study from the Quebec Family Study.
|
PLoS One
|
2013
|
0.84
|
|
138
|
Plasma soluble tumour necrosis factor-alpha receptor 2 is elevated in obesity: specific contribution of visceral adiposity.
|
Clin Endocrinol (Oxf)
|
2009
|
0.83
|
|
139
|
Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy.
|
J Am Coll Cardiol
|
2012
|
0.83
|
|
140
|
Effect of plasma C-reactive protein levels in modulating the risk of coronary heart disease associated with small, dense, low-density lipoproteins in men (The Quebec Cardiovascular Study).
|
Am J Cardiol
|
2003
|
0.83
|
|
141
|
Impact of adiponectin gene polymorphisms on plasma lipoprotein and adiponectin concentrations of viscerally obese men.
|
J Lipid Res
|
2004
|
0.83
|
|
142
|
Insulin resistance and LVH progression in patients with calcific aortic stenosis: a substudy of the ASTRONOMER trial.
|
JACC Cardiovasc Imaging
|
2013
|
0.83
|
|
143
|
PAI-1 activity, but not fibrinogen or von Willebrand factor, is inversely related to LDL particle size in type 2 diabetes.
|
Diabetes Metab Res Rev
|
2008
|
0.83
|
|
144
|
Does correction of the friedewald formula using lipoprotein(a) change our estimation of ischemic heart disease risk? The Quebec Cardiovascular Study.
|
Atherosclerosis
|
2002
|
0.83
|
|
145
|
Influences of the PPAR alpha-L162V polymorphism on plasma HDL(2)-cholesterol response of abdominally obese men treated with gemfibrozil.
|
Genet Med
|
2002
|
0.83
|
|
146
|
Our passive lifestyle, our toxic diet, and the atherogenic/diabetogenic metabolic syndrome: can we afford to be sedentary and unfit?
|
Circulation
|
2005
|
0.83
|
|
147
|
Statins reduce short- and long-term mortality associated with postoperative atrial fibrillation after coronary artery bypass grafting: impact of postoperative atrial fibrillation and statin therapy on survival.
|
Clin Cardiol
|
2012
|
0.83
|
|
148
|
Molecular screening of the 11beta-HSD1 gene in men characterized by the metabolic syndrome.
|
Obes Res
|
2004
|
0.83
|
|
149
|
Oxidized low-density lipoprotein, angiotensin II and increased waist cirumference are associated with valve inflammation in prehypertensive patients with aortic stenosis.
|
Int J Cardiol
|
2009
|
0.82
|
|
150
|
Contribution of apo CIII reduction to the greater effect of 12-week micronized fenofibrate than atorvastatin therapy on triglyceride levels and LDL size in dyslipidemic patients.
|
Ann Med
|
2003
|
0.82
|
|
151
|
A variant in the LRRFIP1 gene is associated with adiposity and inflammation.
|
Obesity (Silver Spring)
|
2013
|
0.82
|
|
152
|
Evidence of QTLs on chromosomes 1q42 and 8q24 for LDL-cholesterol and apoB levels in the HERITAGE family study.
|
J Lipid Res
|
2004
|
0.82
|
|
153
|
Effect of rimonabant on carotid intima-media thickness (CIMT) progression in patients with abdominal obesity and metabolic syndrome: the AUDITOR Trial.
|
Heart
|
2011
|
0.82
|
|
154
|
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association.
|
Circulation
|
2016
|
0.82
|
|
155
|
Association of heterozygous familial hypercholesterolemia with smaller HDL particle size.
|
Atherosclerosis
|
2006
|
0.82
|
|
156
|
Variations in body composition and plasma lipids in response to a high-carbohydrate diet.
|
Obes Res
|
2003
|
0.82
|
|
157
|
Improved plasma FFA/insulin homeostasis is independently associated with improved glucose tolerance after a 1-year lifestyle intervention in viscerally obese men.
|
Diabetes Care
|
2013
|
0.82
|
|
158
|
Transient myocardial tissue and function changes during a marathon in less fit marathon runners.
|
Can J Cardiol
|
2013
|
0.81
|
|
159
|
Impact of visceral obesity on cardiac parasympathetic activity in type 2 diabetics after coronary artery bypass graft surgery.
|
Obesity (Silver Spring)
|
2013
|
0.81
|
|
160
|
Heritability of LDL peak particle diameter in the Quebec Family Study.
|
Genet Epidemiol
|
2003
|
0.81
|
|
161
|
Genome-wide linkage analysis for circulating levels of adipokines and C-reactive protein in the Quebec family study (QFS).
|
J Hum Genet
|
2008
|
0.81
|
|
162
|
Changes in both global diet quality and physical activity level synergistically reduce visceral adiposity in men with features of metabolic syndrome.
|
J Nutr
|
2013
|
0.81
|
|
163
|
Race and sex similarities in exercise-induced changes in blood lipids and fatness.
|
Med Sci Sports Exerc
|
2004
|
0.81
|
|
164
|
The triglyceride/high-density lipoprotein cholesterol ratio, the small dense low-density lipoprotein phenotype, and ischemic heart disease risk.
|
Metab Syndr Relat Disord
|
2004
|
0.81
|
|
165
|
Effects of cholesterol ester transfer protein (CETP) gene on adiposity in response to long-term overfeeding.
|
Atherosclerosis
|
2006
|
0.81
|
|
166
|
Associations of the limb fat to trunk fat ratio with markers of cardiometabolic risk in elderly men and women.
|
J Gerontol A Biol Sci Med Sci
|
2009
|
0.81
|
|
167
|
Angiotensin receptor blockers are associated with reduced fibrosis and interleukin-6 expression in calcific aortic valve disease.
|
Pathobiology
|
2013
|
0.81
|
|
168
|
Effects of long-term overfeeding on plasma lipoprotein levels in identical twins.
|
Atherosclerosis
|
2004
|
0.80
|
|
169
|
Detection of a major gene effect for LDL peak particle diameter and association with apolipoprotein H gene haplotype.
|
Atherosclerosis
|
2005
|
0.80
|
|
170
|
Cardiometabolic effects of rosiglitazone in patients with type 2 diabetes and coronary artery bypass grafts: A randomized placebo-controlled clinical trial.
|
Atherosclerosis
|
2010
|
0.80
|
|
171
|
Angiographically-assessed coronary artery disease associates with HDL particle size in women.
|
Atherosclerosis
|
2012
|
0.79
|
|
172
|
Ectopic visceral fat: a clinical and molecular perspective on the cardiometabolic risk.
|
Rev Endocr Metab Disord
|
2014
|
0.79
|
|
173
|
Amyloid substance within stenotic aortic valves promotes mineralization.
|
Histopathology
|
2012
|
0.79
|
|
174
|
Phosphoinositide cycle gene polymorphisms affect the plasma lipid profile in the Quebec Family Study.
|
Mol Genet Metab
|
2009
|
0.79
|
|
175
|
Plasma leptin response to an epinephrine infusion in lean and obese women.
|
Obes Res
|
2002
|
0.79
|
|
176
|
Relationship between cholesteryl ester transfer protein and LDL heterogeneity in familial hypercholesterolemia.
|
J Lipid Res
|
2004
|
0.79
|
|
177
|
Evidence for a major quantitative trait locus on chromosome 17q21 affecting low-density lipoprotein peak particle diameter.
|
Circulation
|
2003
|
0.79
|
|
178
|
Low-density lipoprotein cholesterol and high-sensitivity C-reactive protein lowering with atorvastatin in patients of South Asian compared with European origin: insights from the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST) study.
|
J Clin Pharmacol
|
2011
|
0.79
|
|
179
|
Combined effects of PPARgamma2 P12A and PPARalpha L162V polymorphisms on glucose and insulin homeostasis: the Québec Family Study.
|
J Hum Genet
|
2003
|
0.79
|
|
180
|
Comparison of prognosis for men with type 2 diabetes mellitus and men with cardiovascular disease.
|
CMAJ
|
2009
|
0.78
|
|
181
|
Insulin resistance, low cardiorespiratory fitness, and increased exercise blood pressure: contribution of abdominal obesity.
|
Hypertension
|
2011
|
0.78
|
|
182
|
Treatment of lipid disorders in obesity.
|
Expert Rev Cardiovasc Ther
|
2011
|
0.78
|
|
183
|
Evidence of QTLs on chromosomes 13q and 14q for triglycerides before and after 20 weeks of exercise training: the HERITAGE Family Study.
|
Atherosclerosis
|
2005
|
0.78
|
|
184
|
Molecular screening of the microsomal triglyceride transfer protein: association between polymorphisms and both abdominal obesity and plasma apolipoprotein B concentration.
|
J Hum Genet
|
2004
|
0.78
|
|
185
|
Lipoprotein lipase in aortic valve stenosis is associated with lipid retention and remodelling.
|
Eur J Clin Invest
|
2013
|
0.78
|
|
186
|
Identifying which patients with diabetes should be tested for the presence of coronary artery disease--the importance of baseline electrocardiogram and exercise testing.
|
Can J Cardiol
|
2006
|
0.78
|
|
187
|
Metabolic and behavioral vulnerability related to weight regain in reduced-obese men might be prevented by an adequate diet-exercise intervention.
|
Appetite
|
2007
|
0.77
|
|
188
|
Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size.
|
Metabolism
|
2003
|
0.77
|
|
189
|
Features of the metabolic syndrome of "hypertriglyceridemic waist" and transplant coronary artery disease.
|
J Heart Lung Transplant
|
2005
|
0.77
|
|
190
|
ApoB/ApoA-I ratio is associated with increased risk of bioprosthetic valve degeneration.
|
J Am Coll Cardiol
|
2013
|
0.77
|
|
191
|
[Treatment of obesity: the need to target attention on high-risk patients characterized by abdominal obesity].
|
Cad Saude Publica
|
2003
|
0.77
|
|
192
|
Impact of gastrointestinal surgery on cardiometabolic risk.
|
Curr Atheroscler Rep
|
2012
|
0.77
|
|
193
|
Adiposity and pulmonary function: relationship with body fat distribution and systemic inflammation.
|
Clin Invest Med
|
2011
|
0.77
|
|
194
|
Endothelin-1 levels and cardiovascular risk factors in renal transplant patients.
|
Clin Biochem
|
2004
|
0.77
|
|
195
|
Apolipoprotein AI- and AI:AII-containing lipoproteins in white men and women of the HERITAGE Family study: Associations with metabolic risk profile variables.
|
Metabolism
|
2003
|
0.76
|
|
196
|
Effect of the factor VII R353Q missense mutation on plasma apolipoprotein B levels: impact of visceral obesity.
|
J Hum Genet
|
2003
|
0.76
|
|
197
|
Improvement of metabolic risk profile under second-generation antipsychotics: a pilot intervention study.
|
Can J Psychiatry
|
2009
|
0.76
|
|
198
|
Lp-PLA2 is associated with structural valve degeneration of bioprostheses.
|
Eur J Clin Invest
|
2013
|
0.76
|
|
199
|
Effects of long-term negative energy balance with exercise on plasma lipid and lipoprotein levels in identical twins.
|
Atherosclerosis
|
2004
|
0.76
|
|
200
|
Low plasma adiponectin exacerbates the risk of premature coronary artery disease in familial hypercholesterolemia.
|
Atherosclerosis
|
2006
|
0.76
|
|
201
|
Impact of a moderate-intensity walking program on cardiometabolic risk markers in overweight to obese women: is there any influence of menopause?
|
Menopause
|
2013
|
0.76
|
|
202
|
Myeloperoxidase gene sequence variations are associated with low-density-lipoprotein characteristics.
|
J Hum Genet
|
2008
|
0.76
|
|
203
|
Targeting Abdominal Adiposity and Cardiorespiratory Fitness in the Workplace.
|
Med Sci Sports Exerc
|
2015
|
0.76
|
|
204
|
High carbohydrate and high monounsaturated fatty acid diets similarly affect LDL electrophoretic characteristics in men who are losing weight.
|
J Nutr
|
2003
|
0.76
|
|
205
|
The Quebec Heart Institute: 50 years of excellence in cardiology.
|
Can J Cardiol
|
2007
|
0.75
|
|
206
|
Genetic aspects of diabetes and its cardiovascular complications: contribution of genetics to risk assessment and clinical management.
|
Can J Cardiol
|
2005
|
0.75
|
|
207
|
Combined use of waist and hip circumference to identify abdominally obese HIV-infected patients at increased health risk.
|
PLoS One
|
2013
|
0.75
|
|
208
|
Exercise-induced exaggerated blood pressure response in men with the metabolic syndrome: the role of the autonomous nervous system.
|
Blood Press Monit
|
2013
|
0.75
|
|
209
|
A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial.
|
Can J Cardiol
|
2009
|
0.75
|
|
210
|
[Assessment of the management of type 2 diabetes].
|
Presse Med
|
2004
|
0.75
|
|
211
|
Impact of abdominal obesity and systemic hypertension on risk of coronary heart disease in men and women: the EPIC-Norfolk Population Study.
|
J Hypertens
|
2014
|
0.75
|
|
212
|
Distinct metabolic and vascular effects of dietary triglycerides and cholesterol in atherosclerotic and diabetic mouse models.
|
Am J Physiol Endocrinol Metab
|
2013
|
0.75
|
|
213
|
[Impact of obesity in contemporary cardiology].
|
Med Sci (Paris)
|
2005
|
0.75
|
|
214
|
Changes in circulating vitamin D levels with loss of adipose tissue.
|
Curr Opin Clin Nutr Metab Care
|
2016
|
0.75
|
|
215
|
Interrelationships between changes in anthropometric variables and computed tomography indices of abdominal fat distribution in response to a 1-year physical activity-healthy eating lifestyle modification program in abdominally obese men.
|
Appl Physiol Nutr Metab
|
2013
|
0.75
|
|
216
|
Genotype of the mutant LDL receptor allele is associated with LDL particle size heterogeneity in familial hypercholesterolemia.
|
Atherosclerosis
|
2006
|
0.75
|
|
217
|
Past dieting is related to rigid control and disinhibition in adolescents from the Québec Family Study.
|
Br J Nutr
|
2012
|
0.75
|
|
218
|
Interaction between Common Genetic Variants and Total Fat Intake on Low-Density Lipoprotein Peak Particle Diameter: A Genome-Wide Association Study.
|
J Nutrigenet Nutrigenomics
|
2015
|
0.75
|
|
219
|
[Obesity and cardiovascular disease].
|
Med Sci (Paris)
|
2003
|
0.75
|
|
220
|
Prevalence of metabolic alterations predictive of cardiovascular disease risk in the Québec population.
|
Can J Cardiol
|
2003
|
0.75
|